JBM (Healthcare) Ltd. (HK:2161) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
JBM (Healthcare) Ltd. reported a strong financial performance for the six months ending September 2024, with revenue climbing 22.1% to HK$399 million and profit from operations surging 41.7% to HK$121.6 million compared to the previous year. The company’s profit attributable to equity shareholders rose by 53.4%, amounting to HK$95.9 million. Additionally, JBM declared an interim dividend increase of 59.4%, highlighting its robust growth and commitment to shareholders.
For further insights into HK:2161 stock, check out TipRanks’ Stock Analysis page.